US2019321295A1PendingUtilityA1
Method of Encapsulating a Nucleic Acid in a Lipid Nanoparticle Host
Est. expiryJul 16, 2034(~8 yrs left)· nominal 20-yr term from priority
A61K 31/713C12N 15/113A61K 48/0091C12N 15/88A61K 31/7105A61K 9/1277C12N 2320/32A61K 48/0008A61K 9/1272C12N 2310/14
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Encapsulated nucleic acid nanoparticles of uniformly small particle size are produced by intersecting one or more nucleic acid streams with one or more lipid streams. The encapsulated nucleic acid nanoparticles include a nucleic acid encapsulated within a lipid nanoparticle host. Uniformly small particle sizes are obtained by intersecting an aqueous nucleic acid stream and a stream of lipids in organic solvent at high linear velocities and with total organic solvent concentrations less than 33%.
Claims
exact text as granted — not AI-modified1 . An encapsulated nucleic acid nanoparticle composition comprising:
a pharmaceutically acceptable carrier; and
an encapsulated nucleic acid nanoparticle, the encapsulated nucleic acid nanoparticle comprising a lipid nanoparticle host and a nucleic acid, the nucleic acid being encapsulated in the lipid nanoparticle host;
wherein the encapsulated nucleic acid nanoparticle has an average particle size of from about 40 nm to about 70 nm and a polydispersity index of less than about 0.1 as determined by dynamic light scattering.
2 . The composition of claim 1 , wherein the lipid nanoparticle host comprises a degradable cationic lipid, a lipidated polyethylene glycol, cholesterol, and 1,2-distearoyl-sn-glycero-3-phosphocholine.Join the waitlist — get patent alerts
Track US2019321295A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.